Skip to content

Long-Term Outcomes of Treatment Strategies for Acute Ischemic Stroke with Medium Vessel Occlusion: A Target Trial Emulation Study Based on Real-World Data

Long-Term Outcomes of Treatment Strategies for Acute Ischemic Stroke with Medium Vessel Occlusion: A Target Trial Emulation Study Based on Real-World Data

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125361
Enrollment
Unknown
Registered
2026-05-26
Start date
2026-02-02
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke

Interventions

Intravascular treatment group:None
Standard medical management:None

Sponsors

Nanjing Drum Tower Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients hospitalized at the participating centers between January 1, 2022, and June 30, 2025; 2. Aged 18 years or older; 3. Pre-stroke modified Rankin Scale score = 1.2; if Option A is not applicable (e.g., some centers lack advanced imaging equipment or analytical software), Option B is used: CT criteria: no hypodensity on non-contrast CT within >= 40% of the hypoperfusion region on perfusion CT; or MRI criteria: diffusion-FLAIR mismatch (no hyperintensity on FLAIR within >= 40% of the diffusion-weighted imaging (DWI) lesion area), with the time window extended to 24 hours); 7. Admission NIHSS score >= 4 or clearly disabling symptoms (e.g., aphasia, hemianopia, etc.).

Exclusion criteria

Exclusion criteria: 1. Concurrent large vessel occlusion; 2. Mild or rapidly improving neurological deficit (prior to any treatment); 3. Imaging suggests the occlusion may be due to other causes (e.g., arterial dissection, vasculitis, moyamoya disease); 4. Presence of other intracranial pathologies that may affect prognosis (e.g., large unruptured aneurysm, arteriovenous malformation, intracranial tumor); 5. History of severe neurological or psychiatric disease that may interfere with neurological assessment; 6. Multiple vessel occlusions (e.g., bilateral anterior circulation or combined anterior and posterior circulation occlusions); 7. Severe systemic disease with a life expectancy of <1 year (e.g., advanced cancer, end-stage liver or kidney failure); 8. Inability to complete follow-up as anticipated.

Design outcomes

Primary

MeasureTime frame
MRS score at 1 year;

Secondary

MeasureTime frame
Functional independence ratio (defined as mRS <= 2);European Five Dimensional Health Scale (EQ-5D-5L) score;Barthel Index score;Patient Health Questionnaire-4 (PHQ-4) Score;

Countries

China

Contacts

Public ContactXu Yun

Nanjing Drum Tower Hospital

xuyun20042001@aliyun.com+86 139 1476 4479

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026